Boianelli, A.; Nordell, P.; Earl, J.; Naylor, J.; Hornigold, D.; Jansson Löfmark, R.; Sundqvist, M.
Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists. Pharmaceutics 2024, 16, 1310.
https://doi.org/10.3390/pharmaceutics16101310
AMA Style
Boianelli A, Nordell P, Earl J, Naylor J, Hornigold D, Jansson Löfmark R, Sundqvist M.
Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists. Pharmaceutics. 2024; 16(10):1310.
https://doi.org/10.3390/pharmaceutics16101310
Chicago/Turabian Style
Boianelli, Alessandro, Pär Nordell, Joseph Earl, Jacqueline Naylor, David Hornigold, Rasmus Jansson Löfmark, and Monika Sundqvist.
2024. "Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists" Pharmaceutics 16, no. 10: 1310.
https://doi.org/10.3390/pharmaceutics16101310
APA Style
Boianelli, A., Nordell, P., Earl, J., Naylor, J., Hornigold, D., Jansson Löfmark, R., & Sundqvist, M.
(2024). Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists. Pharmaceutics, 16(10), 1310.
https://doi.org/10.3390/pharmaceutics16101310
